Literature DB >> 10952150

New combined spasm provocation test in patients with rest angina: intracoronary injection of acetylcholine after intracoronary administration of ergonovine.

S Sueda1, T Ochi, K Yano, K Mineoi, T Kondou, N Ochi, Y Hayashi, H Kukita, S Matsuda, H Kawada, T Tsuruoka, T Uraoka.   

Abstract

The incidence of provoked coronary spasm with the standard single spasm provocation test has been relatively low in patients with rest angina. The present study examined the clinical usefulness of a newly designed spasm provocation test, an intracoronary injection of acetylcholine (ACh) following an ergonovine (ER) test, in patients with rest angina who demonstrated low disease activity and atypical chest pain. Triple sequential spasm provocation tests were performed in 24 patients with atypical chest pain who had no ischemia and in 40 patients with rest angina who had distinct ischemia. Initially, an ACh test (20-100 microg) and then an ER test (40-64 microg) were performed and then, if no spasm was provoked, an intracoronary injection of ACh was given after the ER test to evaluate coronary spasm. Coronary spasm was defined as total or subtotal occlusion. In the 24 patients with atypical chest pain, no spasm was provoked by intracoronary injection of either ACh or ER, but coronary spasms were induced in 2 patients using the new method, with the remaining 22 not experiencing spasm (specificity of new method, 92%). In the 40 patients with rest angina, intracoronary injection of ACh induced coronary spasm in 22 patients (group I) and 6 (group II) demonstrated spasm with intracoronary injection of ER. Coronary spasm was not induced by either the ACh test or the ER test in 12 patients (group III). The intracoronary administration of ACh after the ER test provoked spasm in 11 of 12 patients. Diffuse spasms were provoked in 10 of 11 patients. In patients with rest angina, the frequency of chest pain attacks in 1 month experienced by patients in group III (0.8+/-0.8) was significantly lower than that of patients in group I (7.0+/-5.3, p<0.01) or II (3.5+/-2.3, p<0.05). No serious or irreversible complications related to this new combined method were observed. In conclusion, this method was safe and reliable for the induction of coronary spasm in patients with rest angina who may have low disease activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10952150     DOI: 10.1253/jcj.64.559

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  6 in total

1.  Safety and optimal protocol of provocation test for diagnosis of multivessel coronary spasm.

Authors:  Shozo Sueda; Toru Miyoshi; Yasuhiro Sasaki; Tomoki Sakaue; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2014-11-01       Impact factor: 2.037

Review 2.  Provocative testing for coronary reactivity and spasm.

Authors:  Melody Zaya; Puja K Mehta; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2013-11-06       Impact factor: 24.094

3.  Differential incidence and morphology of provoked spasm between intracoronary acetylcholine and ergonovine testing: recommendation of supplementary use.

Authors:  Shozo Sueda; Kaori Fujimoto; Yasuhiro Sasaki; Tomoki Sakaue; Toyofumi Yoshii; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2018-11-24       Impact factor: 2.037

4.  Moderate vasomotor response to acetylcholine provocation test as an indicator of long-term prognosis.

Authors:  Masahiro Hoshino; Taishi Yonetsu; Akira Mizukami; Yuji Matsuda; Kenji Yoshioka; Yuta Sudo; Ryo Ninomiya; Masao Soeda; Shunsuke Kuroda; Maki Ono; Ryota Iwatsuka; Makoto Suzuki; Akihiko Matsumura; Yuji Hashimoto
Journal:  Heart Vessels       Date:  2016-03-11       Impact factor: 2.037

5.  Gender differences in sensitivity of acetylcholine and ergonovine to coronary spasm provocation test.

Authors:  Shozo Sueda; Toru Miyoshi; Ysuhiro Sasaki; Tomoki Sakaue; Hirokazu Habara; Hiroaki Kohno
Journal:  Heart Vessels       Date:  2014-12-25       Impact factor: 2.037

Review 6.  A Practical Approach to Invasive Testing in Ischemia With No Obstructive Coronary Arteries (INOCA).

Authors:  Alexandra Bastiany; Christine Pacheco; Tara Sedlak; Jaqueline Saw; Steven E S Miner; Shuangbo Liu; Andrea Lavoie; Daniel H Kim; Martha Gulati; Michelle M Graham
Journal:  CJC Open       Date:  2022-05-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.